|
|||
![]() |
|||
2017-03-01 11:00:01 CET 2017-03-01 11:00:01 CET Biohit Oyj - Managers' transactionsBiohit Oyj - Managers' TransactionsBiohit Oyj - Managers' Transactions, March 1, 2017 at 12:00 am local time (EET) Person subject to the notification requirement Name: Hendolin, Panu Position: Other senior manager -------------------------------------------------------------------------------- Initial Notification Reference number: 74370089ATTSNBXJVT29_20170301090243_16 -------------------------------------------------------------------------------- Issuer Name: Biohit Oyj LEI: 74370089ATTSNBXJVT29 -------------------------------------------------------------------------------- Transaction details Transaction date: 2017-02-24 Venue: NASDAQ HELSINKI LTD (XHEL) Nature of the transaction: Exercise (Rights, Put and Call Options) Further details: Linked to stock option programme Instrument: Financial Instrument Linked to a Share or a Debt Instrument ISIN: FI4000219324 Volume: 175 Unit price: 3,40340 Euro Aggregated transactions Volume: 175 Volume weighted average price: 3.40340 Euro -------------------------------------------------------------------------------- Transaction details Transaction date: 2017-02-27 Venue: NASDAQ HELSINKI LTD (XHEL) Nature of the transaction: Exercise (Rights, Put and Call Options) Further details: Linked to stock option programme Instrument: Financial Instrument Linked to a Share or a Debt Instrument ISIN: FI4000219324 Volume: 4589 Unit price: 3,13780 Euro Aggregated transactions Volume: 4589 Volume weighted average price: 3.13780 Euro -------------------------------------------------------------------------------- Transaction details Transaction date: 2017-02-27 Venue: NASDAQ HELSINKI LTD (XHEL) Nature of the transaction: Subscription Further details: Linked to stock option programme Instrument: Financial Instrument Linked to a Share or a Debt Instrument ISIN: FI4000219324 Volume: 2324 Unit price: 2,27660 Euro Aggregated transactions Volume: 2324 Volume weighted average price: 2.27660 Euro -------------------------------------------------------------------------------- Transaction details Transaction date: 2017-02-27 Venue: NASDAQ HELSINKI LTD (XHEL) Nature of the transaction: Disposal Further details: Linked to stock option programme Instrument: Financial Instrument Linked to a Share or a Debt Instrument ISIN: FI4000219324 Volume: 2324 Unit price: 0,00000 Euro Aggregated transactions Volume: 2324 Volume weighted average price: 0.00000 Euro -------------------------------------------------------------------------------- Transaction details Transaction date: 2017-02-27 Venue: NASDAQ HELSINKI LTD (XHEL) Nature of the transaction: Subscription Further details: Linked to stock option programme Instrument: Financial Instrument Linked to a Share or a Debt Instrument ISIN: FI4000219324 Volume: 99 Unit price: 2,27660 Euro Aggregated transactions Volume: 99 Volume weighted average price: 2.27660 Euro -------------------------------------------------------------------------------- Transaction details Transaction date: 2017-02-27 Venue: NASDAQ HELSINKI LTD (XHEL) Nature of the transaction: Disposal Further details: Linked to stock option programme Instrument: Financial Instrument Linked to a Share or a Debt Instrument ISIN: FI4000219324 Volume: 99 Unit price: 0,00000 Euro Aggregated transactions Volume: 99 Volume weighted average price: 0.00000 Euro Additional information: CEO Semi Korpela, Biohit Oyj tel. +358 9 773 861 investor.relations@biohit.fi www.biohithealthcare.com Biohit in brief Biohit Oyj is a globally operating Finnish biotechnology company. Biohit’s mission is “Innovating for Health” – we produce innovative products and services to promote research and early diagnosis. Biohit is headquartered in Helsinki, Finland, and has subsidiaries in Italy and the UK. Biohit's Series B share (BIOBV) is quoted on Nasdaq Helsinki in the Small cap/Healthcare group. www.biohithealthcare.com |
|||
|